NDC 61919-851

TRANSDERM-IQ

Transderm-iq

TRANSDERM-IQ is a Topical Ointment in the Human Otc Drug category. It is labeled and distributed by Direct_rx. The primary component is Capsaicin; Menthol, Unspecified Form; Methyl Salicylate; Lidocaine.

Product ID61919-851_8e822dc1-f771-0c86-e053-2a95a90afff5
NDC61919-851
Product TypeHuman Otc Drug
Proprietary NameTRANSDERM-IQ
Generic NameTransderm-iq
Dosage FormOintment
Route of AdministrationTOPICAL
Marketing Start Date2019-07-25
Marketing CategoryOTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL
Application Numberpart348
Labeler NameDirect_Rx
Substance NameCAPSAICIN; MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE; LIDOCAINE
Active Ingredient Strength0 g/100g; g/100g; g/100g; g/100g
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 61919-851-04

113 g in 1 TUBE (61919-851-04)
Marketing Start Date2019-07-25
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 61919-851-04 [61919085104]

TRANSDERM-IQ OINTMENT
Marketing CategoryOTC monograph not final
Application Numberpart348
Product TypeHUMAN OTC DRUG
Billing UnitGM
Marketing Start Date2019-07-25

Drug Details

Active Ingredients

IngredientStrength
CAPSAICIN.0375 g/100g

OpenFDA Data

SPL SET ID:8e822dc1-f770-0c86-e053-2a95a90afff5
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1876751
  • NDC Crossover Matching brand name "TRANSDERM-IQ" or generic name "Transderm-iq"

    NDCBrand NameGeneric Name
    61919-851TRANSDERM-IQTRANSDERM-IQ
    70364-001Transderm-iQCapsaicin, Lidocaine, Menthol, Methyl Salicylate

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.